Elekta AB (publ) (STO: EKTA.B)

Market Cap	24.07B
Revenue (ttm)	18.12B
Net Income (ttm)	1.13B
Shares Out	382.08M
EPS (ttm)	2.97
PE Ratio	21.23
Forward PE	13.20
Dividend	2.40 (3.81%)
Ex-Dividend Date	Mar 6, 2025

Volume	244,848
Open	63.10
Previous Close	63.00
Day's Range	61.60 - 63.40
52-Week Range	61.45 - 90.00
Beta	1.11
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2024

About Elekta AB

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, suc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1972
• Employees: 4,718
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: EKTA.B

Financial Performance

In 2024, Elekta AB's revenue was 18.12 billion, an increase of 7.41% compared to the previous year's 16.87 billion. Earnings were 1.30 billion, an increase of 38.07%.